432s Posters, Tuesday, 3 I October 2000 600 mg of moclobemide daily in combination with psychodynamic psychotherapy. We amplified our clinical observations with findings of the Liebowitz Social Phobia Scale and the Sheenan Scale. The duration of research was 3 months. We observed two groups of patients -with generalized (GSP) and isolated (ISP) forms of SP The positive effect of treatment was marked in group GSP about 38.2% and in ISP about 26.6% cases. For both groups reduction of symptoms was began since the 3-4 weeks and the significant gain in function and quality of life was noticed from IO-12 weeks from the start of therapy. We found that effect of moclobemide in cases of GSP was higher that could be explained by strongly pronounced level of comorbidity and social desadaptation at this group. In patients with ISP the use of psychodynamic psychotherapy was preferably to some extent through they higher demands towards non-drugs and personal-oriented methods of treatment.

No abstract

No abstract

No abstract